← Back to Search

Aliviado DSD Program for Dementia Caregivers

N/A

Recruiting

Led By Shih-Yin Lin

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

To be eligible to participate in the feasibility trial, an individual must meet all of the following criteria: Being 18 years old or older, English-speaking, Providing at least 8 hours of unpaid care per week to, or living with, a community dwelling PLWD whose Delirium Risk Assessment Score >=5, Having the capacity to give informed consent, and Having a smartphone with Internet access.

To be eligible as a "dementia caregiver" in the co-design workshop, an individual must: be at least 18 years old, be English-speaking, provide at least 8 hours of unpaid care weekly or live with a community-dwelling PLWD, self-identify as unfamiliar with DSD, have the capacity to consent, and have Internet access

Must not have

Individuals who are blind or deaf will be excluded.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 6

Awards & highlights

No Placebo-Only Group

Summary

This trial will develop and test an mHealth program to help family caregivers of dementia patients detect and manage delirium.

Who is the study for?

This trial is for English-speaking adults who provide at least 8 hours of unpaid care weekly or live with someone with dementia at high risk for delirium. They must be unfamiliar with DSD, able to consent, and have internet access via smartphone. Blind or deaf individuals cannot participate.

What is being tested?

The study tests the 'Aliviado DSD Caregiving Mastery Program,' designed to help family caregivers manage Delirium superimposed on Dementia (DSD) through a mobile health app and educational content over a 5-week workshop.

What are the potential side effects?

Since this intervention involves education and use of an mHealth app rather than medication, traditional side effects are not applicable. However, participants may experience stress or emotional discomfort while learning to manage DSD.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 18, speak English, care for someone with dementia without pay, don't know much about DSD, can consent, and have Internet.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am not blind or deaf.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 6 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Modified IBM Computer Usability Satisfaction Questionnaire Score

Number of Participants who Complete Weekly Delirium Screening at Least Twice by Week 6

Number of Participants who Complete all Training Videos by Week 2

+2 more

Secondary study objectives

Change from Baseline in Caregiver Delirium Knowledge Questionnaire Score at Week 2

Change from Baseline in Caregiver Delirium Knowledge Questionnaire Score at Week 6

Change from Baseline in Center for Epidemiological Studies Depression Scale (CES-D) Score at Week 6

+4 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Family Caregivers of PLWD at High Risk for DeliriumExperimental Treatment1 Intervention

Participants will complete the Aliviado DSD Caregiving Mastery Program. This involves a caregiver education/training period from Week 0 to Week 2, and an implementation period from Week 3 to Week 6.

0 / 3Eligibility criteria met